Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Shinagawa, TokyoFounded 19811,085 employeesWebsite
A medical device manufacturer and distributor specializing in cardiovascular care. It develops, imports, and sells products such as pacemakers and catheters, with strengths in arrhythmia treatment.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Electrophysiology and Ablation | 49% | ¥29.1B | ¥0 | 0.0% |
| Cardiac Rhythm Devices | 22% | ¥13.1B | ¥0 | 0.0% |
| Cardiovascular Medical Devices | 21% | ¥12.7B | ¥0 | 0.0% |
| Cerebrovascular Medical Devices | 4% | ¥2.7B | ¥0 | 0.0% |
| Gastrointestinal Medical Devices | 3% | ¥1.7B | ¥0 | 0.0% |
Close (Oct 30, 2026)
¥1,590+9.4% (1Y)
Japan Lifeline +9.4% over 1Y, 2.8pt above the industry average (9 companies, +6.5%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥59.2B | ¥12.6B | ¥9.3B | ¥80.2B | — |
Sources: annual securities reports, earnings releases and other public disclosures (Dec 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
